IDHC — Integrated Diagnostics Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
$316.24m
Enterprise Value
$320.70m
Revenue
EGP7.86bn

Annual income statement for Integrated Diagnostics Holdings, fiscal year end - December 31st, EGP millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,225	3,605	4,123	5,720	7,855
Cost of Revenue
Gross Profit	2,804	1,462	1,524	2,182	3,353
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,963	2,773	3,385	4,505	5,682
Operating Profit	2,262	832	738	1,214	2,173
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,232	854	737	1,440	2,119
Provision for Income Taxes
Net Income After Taxes	1,493	527	468	1,008	1,302
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,413	541	510	1,077	1,262
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,413	541	510	1,077	1,262
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.35	0.925	0.901	1.85	2.17
Dividends per Share